ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2459
0,81%
Bitcoin
67.219,29
-1,67%
Brent Oil
81,295
-0,80%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Gritstone bio Inc (GRTS)

  7. Gritstone bio Inc (GRTS) Notícias

GRTS

Gritstone bio (GRTS)

Gritstone bio Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GRTS
DataHoraFonteTítuloCódigoCompanhia
17/05/202422:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRTSGritstone bio Inc
10/05/202417:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GRTSGritstone bio Inc
09/05/202417:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTSGritstone bio Inc
09/05/202417:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTSGritstone bio Inc
09/05/202417:05GlobeNewswire Inc.Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
02/05/202417:05GlobeNewswire Inc.Gritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024NASDAQ:GRTSGritstone bio Inc
30/04/202408:00GlobeNewswire Inc.Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024NASDAQ:GRTSGritstone bio Inc
29/04/202408:00GlobeNewswire Inc.Gritstone bio Announces Appointment of Stephen Webster to its Board of DirectorsNASDAQ:GRTSGritstone bio Inc
15/04/202408:00GlobeNewswire Inc.Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)NASDAQ:GRTSGritstone bio Inc
08/04/202409:00GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor and Scientific ConferencesNASDAQ:GRTSGritstone bio Inc
08/04/202408:00GlobeNewswire Inc.Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024NASDAQ:GRTSGritstone bio Inc
02/04/202400:00GlobeNewswire Inc.Gritstone bio Announces Pricing of $32.5 Million Underwritten Public OfferingNASDAQ:GRTSGritstone bio Inc
01/04/202417:10GlobeNewswire Inc.Gritstone bio Announces Proposed Public OfferingNASDAQ:GRTSGritstone bio Inc
01/04/202417:01GlobeNewswire Inc.Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite StaNASDAQ:GRTSGritstone bio Inc
05/03/202418:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GRTSGritstone bio Inc
05/03/202418:05GlobeNewswire Inc.Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
29/02/202418:05GlobeNewswire Inc.Gritstone bio Announces Workforce Reduction NASDAQ:GRTSGritstone bio Inc
13/02/202414:44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRTSGritstone bio Inc
12/02/202409:00GlobeNewswire Inc.Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical TrialNASDAQ:GRTSGritstone bio Inc
08/02/202418:30GlobeNewswire Inc.Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GRTSGritstone bio Inc
17/01/202409:00GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor ConferenceNASDAQ:GRTSGritstone bio Inc
02/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GRTSGritstone bio Inc
22/12/202318:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GRTSGritstone bio Inc
20/11/202309:00GlobeNewswire Inc.Gritstone bio to Participate in Upcoming Investor ConferencesNASDAQ:GRTSGritstone bio Inc
08/11/202318:05GlobeNewswire Inc.Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:GRTSGritstone bio Inc
12/10/202318:00GlobeNewswire Inc.Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA AwardNASDAQ:GRTSGritstone bio Inc
11/10/202308:10GlobeNewswire Inc.Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 VaccineNASDAQ:GRTSGritstone bio Inc
04/10/202317:05GlobeNewswire Inc.Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023NASDAQ:GRTSGritstone bio Inc
27/09/202317:01GlobeNewswire Inc.Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 MillionNASDAQ:GRTSGritstone bio Inc
15/08/202308:00GlobeNewswire Inc.Gritstone bio and Genevant Sciences Announce Option and License AgreementNASDAQ:GRTSGritstone bio Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:GRTS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
RCSL4
RECRUSUL PN
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
HAGA3
HAGA ON
BOV
RPMG3
PET MANGUINH ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
GOLL4
GOL PN
BOV
AMER3
Americanas ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
COGN3
COGNA ON
BOV
RCSL3
RECRUSUL ON
BOV
TPIS3
TRIUNFO PART ON
BOV
SGPS3
SPRINGS ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
CIEL3
CIELO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados